Related Experiment Videos
Enzyme release from cultured human melanoma cells
E Karg1, B Hultberg, A Isaksson
1Department of Dermatology, University of Lund, Sweden.
Acta Dermato-Venereologica
|January 1, 1990
Summary
Beta-hexosaminidase and tyrosinase enzymes were studied in melanoma cells. Released enzymes suggest potential tumor markers for malignant melanoma and indicate active enzyme release by cancer cells.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Malignant melanoma is a significant health concern.
- Understanding enzyme activity in melanoma cells is crucial for diagnosis and treatment.
- Lysosomal and melanocyte-specific enzymes are key cellular components.
Purpose of the Study:
- To investigate the release of beta-hexosaminidase and tyrosinase from human melanoma cell cultures.
- To determine if enzyme release is indicative of cell viability.
- To explore the potential of these enzymes as biomarkers for malignant melanoma.
Main Methods:
- Culturing human melanoma cells.
- Measuring beta-hexosaminidase and tyrosinase activity in both cells and culture medium over 24 and 48 hours.
- Assessing lactate dehydrogenase activity to confirm cell membrane integrity.
Main Results:
- Beta-hexosaminidase activity in the medium increased significantly over time, exceeding cellular activity after 48 hours.
- Tyrosinase activity was also detected in the medium, increasing from 5% to 19% over 48 hours.
- Low lactate dehydrogenase levels indicated that enzyme release was not due to cell damage.
Conclusions:
- Beta-hexosaminidase shows promise as a potential tumor marker for malignant melanoma.
- Tyrosinase activity in melanoma patient sera may partly originate from viable cancer cells.
- These findings support the use of enzyme analysis in melanoma diagnostics.